Recombinant adenoviruses are presently the most efficient in vivo gene transfer system available. Targeting single organs or large tumors by adenoviral vectors requires an intravascular route of application. During the first pass of viral particles through the vascular bed of the target tissue, virus uptake is not quantitative and undefinite amounts of particles leak into circulation. To determine the amount of leaking particles and to calculate organ-specific uptake (in-/outflow ratio), it is necessary to titrate virus particles directly in blood. In preclinical and clinical trials titration is currently mostly done with blood plasma instead of full blood. However, this technique provides valid results only as long as there is no affinity between adenovirus particles and erythrocytes. In this study we demonstrate that Ad5 particles, as mostly employed for gene therapy, have a strong affinity to human erythrocytes. At 60 min after coincubation of human erythrocytes and Ad5 particles, more than 98% of the particles are attached to the surface of erythrocytes. Therefore, ignoring the amount of red cell bound particles by performing titration in plasma leads to severe miscalculation of organ-specific transfer rates or virus circulation half-life. The biological impact of an increased affinity between virus particles and erythrocytes will be discussed.
Introduction General
Recombinant adenoviruses hold a particular strong potential for in vivo gene therapy since most human tissues and cell types are easily accessible for adenoviral vectors. 1 This property makes them applicable to a large number of therapeutic options but the same property makes it difficult to restrict gene transfer to the desired target tissue (ie tumors, liver, heart). In clinical trials for the treatment of inherited liver diseases or ischemic heart problems, local restriction has been aimed by intravascular vector application (hepatic artery, coronary artery). 2, 3 However, this route of application cannot prevent large viral quantities to bypass the target tissue and to enter the circulation. 4, 5 The amount of viral particles and their half-life in the circulation is an essential parameter that influences biodistribution into nontarget tissues and systemic side effects. 6 Monitoring the amount of virus particles spread into circulation is therefore an important safety measure.
In this study we show that viral particles could have a strong propensity to adhere to red blood cells, a phenomenon demonstrable by hemagglutination assays. Moreover, the affinity of adenovirus particles to mammalian erythrocytes varies substantially between species, which has to be considered carefully when transferring data from animal to clinical trials in adenoviral gene therapy. Measuring virus titers in blood plasma instead of using full blood is currently common practice and indicates that people are not aware of any interactions between adenoviral particles and cellular components of the blood that finally leads to miscalculation of virus titers in the circulation.
The affinity between adenovirus particles and erythrocytes
We have analyzed hemagglutination properties and the specific affinity of purified human adenoviruses (Ad1, 3, 4, 5, 9, 12 and 15) to erythrocytes of different species (mice, rats, rabbits and humans). Hemagglutination assays have been done in the past for serotyping of human adenoviruses. Crude cell lysates or virus-infected cells were usually utilized as virus source in these assays. Hence, literature data regarding hemagglutination properties of human adenoviruses are therefore based on protocols employing unpurified virus preparations. However, we have found that crude preparations behave differently from purified virus preparations with respect to hemagglutination properties. As opposed to literature data and the generally accepted view that Ad5 virus is not able to mediate hemagglutination of human red blood cells, [7] [8] [9] our results clearly demonstrates hemagglutination of human red blood cells by Ad5 viruses. In blood, the increased affinity between Ad5 particles and human erythrocytes induces rapid binding of virus particles by red cells. After 1 h coincubation, more than 98% of virus particles are attached to the erythrocyte surface. These data clearly demonstrate that using blood plasma as a source for measuring virus titers will lead to high overestimation of organ transfer rates and underestimation of circulation half-life.
Hemagglutination
Hemagglutination reflects the ability of virus particles to bind erythrocytes in a specific polyvalent manner. The component on the surface of the viral capsid that is responsible for erythrocyte binding is the gamma domain of the fiber protein. 10 Switching the gamma domain between different serotypes with different hemagglutination properties changes their red-cell affinity. 10, 11 In the past hemagglutination properties of human adenoviruses have been employed for serotyping in clinical routine, but nowadays PCR analysis and the avaliability of type-specific antibodies have superseded this technique. 12 The interest in adenoviral fiber proteins has gained a renaissance since it has been shown that this protein is mainly responsible for cell tropism of adenoviral vectors. 13 Whether the described affinity between erythrocytes and adenoviruses could influence gene transfer efficiency, biodistribution or immunological side effects remains unclear. We will discuss possible implications with respect to side effects of adenoviral gene transfer observed in animal models.
Materials and methods

Adenoviral procedures
Adenovirus wild-type specimens of serotype 1, 3, 4, 5, 9, 12 and 15 were provided by the Institute of Virology of the Medizinische Hochschule Hannover, Germany. Wildtype viruses were grown on HeLa and A549 cells. Recombinant-serotype 5-derived adenoviruses encoding the human p53 gene were kindly provided by Wei-Wei Zhang (Anderson Cancer Center, Houston, USA), and recombinant adenoviruses encoding the human alpha-1-antitrypsin (hAAT) gene and bacterial b-galactosidase (lacZ) were kindly provided by Mark Kay (Stanford University, USA). A recombinant virus encoding the gene for the human LDL receptor was generated according to the procedure of Graham. 14 Recombinant viruses were propagated on 293 cells and lysed by three freeze-thaw cycles. The purification procedure was the same for wild-type and recombinant viruses. In brief, purification was performed by two rounds of cesium chloride density gradient centrifugation and cesium chloride was removed by gel filtration on Sephadex G-25 columns (Pharmacia, Uppsala, Sweden). Equilibration was performed with a buffer containing 3 mM KCl, 1 mM MgCl 2 , Phosphate-buffered saline (PBS). Sterile filtration was carried out using a 0.45 mM filter (Schleicher und Schuell FP 030/2, Dassel, Germany). Virus suspensions were supplemented with 10% glycerol and stored in aliquots at À781C. The amount of infectious particles was determined by end point dilution assays as described in the paragraph 'Titration techniques'. The concentration of physical particles was measured spectrophotometrically as described by Mitteredder et al. 15 Biological titers were stated as infectious particles (i.p.)/ml and physical titers as particles/ml. 
Hemagglutination analysis
Blood was obtained from healthy volunteers by cubital vein puncture. Additional samples were kindly provided from the blood bank of the Charité. NMRI mice (Bomholtgard, Ry, Denmark) and Wistar rats (Charles River, Sulzfeld, Germany) were bled from the retroorbital plexus and New Zealand While rabbits (Charles River, Sulzfeld, Germany) by artery puncture of the ear. Anticoagulation of all blood specimens was performed with ethylenediaminetetraacetic acid (EDTA) immediately after withdrawl. For blood collection, in humans, EDTA-Vacuutainer system (Belliver Industrial Estate, Plymouth, UK) and, in animals, Minicollect EDTA tubes (Greiner bio-one, Essen, Germany) were employed. Undiluted, anticoagulated blood is only called EDTA full blood in the following text. The blood was diluted to 1% erythrocyte density with PBS and washed five times by repealed centrifugation (10 min/1500 g)/resuspension cycles. After the last wash, erythrocytes were resuspended in 5% bovine serum albumin (BSA, Sigma, Deisenhofen, Germany)/PBS. Adenovirus stock solutions were diluted by factor 1/2, 1/4, 1/8 y 1/256 in 5% BSA/PBS. A total of 50 ml 1% erythrocyte suspension was prelayed in each well of concave-bottom-shaped 96-well plates (U-bottom 96-well cell culture cluster, Costar, NY, USA), and 50 ml of virus dilutions (1/2-1/256) were added and gently mixed with the erythrocyte suspension. After 2 h sedimentation was finished and the plates were analyzed for hemagglutination patterns. For generation of crude cell lysates of virus-infected cells, 15 cm plates of 293 cells were grown to a density of 70% and infected with Ad-lacZ, Ad-hAAT and Ad-hLDL. At 2 days after infection cells were gently harvested, pelleted and resuspended in 1 ml complete medium. Three freeze-thaw cycles were performed, cell debris was pelleted by centrifugation and supernatant was used for hemagglutination-inhibition studies. For control experiments, uninfected cell were harvested and treated in the same manner.
Inhibition studies were performed by adding one volume of cell lysate to the same volume of virus stock solution (1:1). Further dilutions were done with PBS/ BSA as described above.
Erythrocyte binding studies
EDTA blood from mice, rats, rabbits and humans (three individuals each species) were taken as described above, washed five times and adjusted to 40% erythrocyte suspensions in 5% BSA/PBS. A 2 Â 200 ml volume of erythrocyte suspensions (each subject) were incubated with 20 ml of virus suspension containing 1 Â 10e 7 i.p. and 1 Â 10e 8 i.p. Ad-lacZ, respectively (particle/i.p. ratio 10:1). The number of erythrocytes in 200 ml 40% solution was calculated to be 1 Â 10e 9 , which renders the erythrocyte/infectious particle ratio to be 100/1 and 10/1, respectively. After 60 min at 371C the suspension Titration of Ad5 in blood G Cichon et al was shortly vortexed and 2 Â 20 ml were taken for titration. The rest was centrifugated for 3 min at 12 000 r.p.m. and again 2 Â 20 ml virus supernatant were taken for titration.
Kinetics of red-cell binding
A volume at 100 ml aliquots of 40% washed erythrocyte preparations from humans, rats, rabbits and mice (three individuals each) were incubated with 10 ml of Ad-lacZ containing 5 Â 10e 7 i.p. Ad-lacZ. After 30 s and 1, 2, 5, 10, 30 and 60 min incubation time, red cells were pelleted by centrifugation and the amount of virus remaining in the supernatant was determined by titration. In control samples, the same amount of virus was added to 100 ml PBS.
Titration techniques
In all, 3 Â 10e 3 293 cells in 120 ml complete medium (Dulbecco's modified eagle medium (DMEM), 10% fetal calf serum (FCS)) were seeded in 96-well plates on the day prior to the tests. For titration, the undiluted erythrocyte-adenovirus suspensions and supernatants were serially diluted in complete medium. Dilutions were performed in two 10/1 steps followed by 10/3 steps. A total of 20 ml of each dilution was transferred to one well on the 96-well plates containing the 293 cells. Six dilutions for each specimen were done in parallel. At 4-5 days after infection, CPE was noted the first time and cells from higher dilutions (where no CPE was observed up to this point) were transferred to a 24-well plate (well to well) containing 1 ml fresh medium. After an additional observation period of 5-7 days, the final CPE was noted and the titers calculated.
In a different approach, the amount of virus particles remaining in the supernatants were determined by measuring the lacZ activity on Huh7 cells 2 days after transferring aliquots of the supernatants on cultured Huh7 cells. The day prior to infection 8 Â 10e 4 Huh7 cells in 1 ml complete medium (10% FCS, DMEM) were seeded in 24-well plates (density next day about 50-70%). Infection was performed by adding 20 ml of the undiluted supernatants directly into the medium of the Huh7 cells. After 48 h, cells were washed twice with PBS, harvested, lysed in the galactolight lysis buffer (Tropix, Bedford, MA, USA). The lacZ expression was determined employing a galactolight kit (Tropix, Bedford, MA, USA) in a luminometer (Berthold Lumat LB 9501, Wildbad, Germany).
Virus titration in EDTA full blood
A 100 ml measure of EDTA full blood of rabbits, rats, mice (n¼3) and one human (with no antiadenoviral antibodies) was incubated with 10 ml virus suspension containing 5 Â 10e 8 i.p. Ad-lacZ. In parallel, the same amount of virus was added to 100 ml PBS. After 1 h at 371C, the blood specimens and the control samples were shortly vortexed and directly employed for titration in a serial dilution assay as described above.
Results
Hemagglutination
Hemagglutination studies with purified wild-type adenovirus preparations and human red cells reveal an increased affinity to Ad 4, 5, 9 and 15 and no affinity to Ad 1, 3 and 12 (Table 1, Figure 1 ). These findings correspond to literature data with respect to HA patterns of Ad 1, 3, 9 and 12. 7, 9 In contrast to literature data, Ad4 and Ad15 induce a mild hemagglutination, whereas again divergent from literature data Ad5 induces substantial hemagglutination of human erythrocytes. To evaluate the individual variability in hemagglutination patterns, 16 randomly collected blood samples (blood groups known) were tested for hemagglutination with Ad5 viruses. HA was present in all samples regardless of the underlying blood group. Figure 2 shows five samples representing different blood groups (ABO, Rh). No differences in HA pattern was noticed when using viruses encoding different transgenes (Ad-lacZ, Adp53, Ad-hAAT and Ad-hLDL). The hemagglutination Figure 1 Hemagglutination patterns of human erythrocytes after incubation with purified preparations of human wild-type adenoviruses. A measure of 50 ml of 1% suspension of washed human erythrocytes were prelayed and 50 ml of virus dilutions were added and suspension was gently mixed. After 2 h, sedimentation had finished and hemagglutination patterns was analyzed. In the absence of any hemagglutination the erythrocyte sediment forms a small, sharply rounded dot (control, Ad1, Ad3, Ad12). In case of positive HA patterns, erythrocytes and adenoviruses form a more complex structure that appears as a blurred large sediment (Ad4, Ad5, Ad9, Ad15). 
À=no HA visible, +=short range (partial) HA, ++=medium range HA, +++=long range (complete) HA.
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patterns between Ad5 and human erythrocytes show a prozone phenomenon. When the particle/erythrocyte ratio is higher than about 10 000/1, hemagglutination disappears. In the presence of excess amounts of virus particles the erythrocyte surface becomes saturated with particles, which prevents single particles from binding two erythrocytes at the same time. This finding demonstrates that screening for hemagglutination patterns should be done at varying particle/erythrocyte ratios. Hemagglutination between Ad5 and human erythrocytes occurs at a ratio of about 10 000/1 (dilution 1/4) and disappears beyond 200/1 (dilution 1/256) ( Figure 1) .
Analyzing hemagglutination between species (mice, rabbits, rats and humans) and Ad5 particles showed no hemagglutination with mice and rabbit erythrocytes and positive patterns in rats and humans (Table 1) .
Reason for divergency to literature data
According to the literature Ad5 does not hemagglutinate human erythrocytes. [7] [8] [9] This finding need to be revised in part since we could demonstrate that the purity of the virus source could influence hemagglutination patterns. Using crude cell lysates of Ad5-virus-infected cells for hemagglutination (as it was usually done in the past) with human erythrocytes does not induce hemagglutination. Employing purified virus leads to hemagglutination (Figures 1-3) . If we added crude lysate of virus-infectedcells, but not from uninfected cells, to the assay, hemagglutination was blocked completely (Figure 3) . Obviously, crude cell lysates of infected cells contain soluble factors that interfere with hemagglutination and which are removed during the virus purification procedure. We did not characterize the nature of these factors further.
Quantification of erythrocyte binding
Initially we raised the question whether binding of virus by erythrocytes leads to any form of inactivation or loss of infectivity. We added a definite amount of virus to blood samples (anticoagulated with EDTA) of mice, rats, rabbits and one human being (with no antiadenoviral antibodies). After 1 h coincubation at 371C, the specimens were briefly vortexed and virus titration was performed in EDTA blood specimens directly. No difference was noted between virus titers determined in the control samples (PBS) and the EDTA full blood samples.
The outcome demonstrates that red cell bound virus particles are still infective and their amount can be determined by common titration techniques.
The fact that erythrocyte bound viruses could be titered in routine assays allowed the determination of the ratio of red cell bound and unbound virus in a simple experimental setting. In parallel, specimens of washed erythrocytes from mice, rats, rabbits and humans were incubated with a definite amount of virus for 1 h at 371C. After brief vortexing, virus titers were determined directly in the red cell suspension and (after pelleting the erythrocytes by centrifugation) in the supernatant. In case of no difference between the corresponding samples it can be concluded that no virus adhered to the erythrocyte surface. In case of an increased affinity to red cells the titer in the raw erythrocyte suspension was expected to be higher than the one in the supernatant.
The outcome shows good accordance with hemagglutination patterns of the four explored species. In mice and rabbits specimens (no hemagglutination with Ad5), the titers in the supernatant reached about 73 and 86%, respectively, compared to the amount determined in the red cell suspension directly. These values suggest the presence of mild adhesion forces between red cell and virus particles. In rats and humans (hemagglutination positive with Ad5), titers between erythrocyte suspension and supernatant differed substantially. In humans, less than 1.2% and in rats about 0.4% of viruses remained unbound after 1 h, while the remaining amount was attached to the surface of red cells (Figure 4) . The outcome demonstrates the presence of an enhanced specific affinity of Ad5 and erythrocytes derived from rats and humans.
Speed of virus binding
To determine the speed of virus binding, we incubated virus and 40% erythrocyte suspensions of mice, rats, rabbits and humans and pelleted the red cells at different time points (30 s, and 1, 2, 5,10, 30 and 60 min). The amount of viruses remaining in the supernatant was determined. In samples derived from mice and rabbits the comparison revealed a mild affinity between virus particles and red cells. Since no further alteration in the amount of unbound particles was found beyond 5 min of incubation, this binding behavior might reflect an unspecific adsorption phenomenon to take place. In rats, 90% of viruses were already attached to the surface of Titration of Ad5 in blood G Cichon et al erythrocytes 5 min after coincubation. This value increased to 99% 10 min after incubation tending towards 100% in the following hour. In humans, 10 min after incubation, about 75% of particles were bound. This values also increases in time reaching 98.8% after 1 h ( Figure 5 ).
Discussion
The affinity of Ad5 and human erythrocytes Hemagglutination is an adenoviral property that results from the ability of viral particles to adhere to the surface of erythrocytes in a polyvalent manner. Therefore, hemagglutination patterns of adenovirus particles deserve attention in gene therapy since they provide an initial prediction regarding expectable interactions of virus particles and cellular components of the blood.
According to literature data Ad5 is not able to hemagglutinate human erythrocytes. 7, 9 The explanation for the divergent findings of the actual study lies in the purity of the employed virus source. Ad 5 particles which have been purified from crude lysates of virusinfected cells are able to hemagglutinate human erythrocytes very efficiently. Unpurified lysates contain soluble factors that are able to block hemagglutination of Ad5 and human erythrocytes completely. The fact that only lysates from Ad5-infected, but not from uninfected, host cells block hemagglutination suggests that these factors are encoded by the virus genome.
Curiously, the ability of crude cell lysates to inhibit hemagglutination is restricted to certain combinations of adenoviral serotypes and mammalian erythrocytes. Crude lysates of Ad5-virus-infected cells are able to hemagglutinate rat erythrocytes quite efficiently. One would expect that the same mechanism would apply to rat erythrocytes as well, but obviously the specific adhesion forces between Ad5 and rat erythrocytes are different or less accessible to competing factors.
In summary, the results demonstrate that literature data based on classical hemagglutination assays do not allow to predict the expectable affinity between adenovirus particles and mammalian erythrocytes. To obtain valid results regarding possible interactions of virus particles and red cells, it requires elimination of possibly interfering factors by employment of purified virus preparations.
The impact for gene therapy
The fact that Ad5 particles have a strong affinity to human and rat erythrocytes has not been considered in gene therapy studies so far. The relevance of this phenomenon for virus titration in blood or blood plasma, respectively, is evident. The amount of erythrocyte bound particles could reach 99% within less than 1 h. Ignoring this amount by determining 'blood' titers in plasma leads to strong miscalculation of organ transfer rates based on input/output ratios or of circulation halflife. The fact that the affinity between adenoviruses and erythrocytes persists also ex vivo should be considered for handling of tubes after blood samples have been withdrawn from patients or animals.
Red cell bound viruses are still infective which allows quantification by conventional titration techniques. Anticoagulated full blood (instead of plasma) can be taken directly for titration in serial dilution assays. In lower dilutions, large amounts of erythrocytes are present in each well but in higher dilutions their presence does not interfere with the reliable identification of virus-infected cells and cytopathic effect (CPE).
Biological aspects
The relevance of adenoviruses-red cell affinity for biological or physical aspects of adenoviral gene transfer remains to be clarified. The majority of preclinical gene therapy studies are done in mice. Mice red cells have no specific affinity to Ad5. They share this property with rabbits and domestic pigs. In contrast to this rats and humans have a high affinity to Ad5. It is noteworthy that there is a coincidence between increased sensitivity against Ad5 and positive hemagglutination patterns as deduced from recent toxicity studies performed with Ad5 in rats, mice and domestic pigs. 16, 17 Morrissey et al demonstrated that the majority of rats (Sprague-Dawley) died within hours after systemic application of 1.1 Â 10e l2 Ad5 particles/kg. This dose is tolerated by mice, 17 pigs 16 and rabbits 4 without serious problems. The authors speculated about a possible relation between Figure 4 Washed erythrocyte solutions (40%) of mice, rabbits, rats and human (n¼3) were incubated with Ad-lacZ (Ad5). After 1 h at 371C, virus titers were determined directly in the briefly vortexed raw erythrocytevirus suspension and (after pelleting red cells by centrifugation) in the supernatant. The difference between both titers allows to calculate the amount of erythrocyte bound virus particles. In mice, 73% and in rabbits 86% of virus particles remain unbound, while in rats only 0.4% and in humans 1.2% of viruses remain in the supernatant. Titration of Ad5 in blood G Cichon et al hemagglutination and toxicity in rats, but they could not provide evidence for this hypothesis on the basis of interindividual differences in hemagglutination patterns and the sensitivity against at Ad5 in single animals. The interindividual differences (within a species) in the affinity of red cell and Ad5 might not be extended enough to correlate with the extent of toxic side effects. Further, the sensitivity against Ad5 is not specific for Sprague-Dawley rats. It can be found in Wistar rats as well (own unpublished data) and seems to be a general feature of rats. At present it remains speculative whether the coincidence of hemagglutination and toxicity has a pathophysiological basis. However, the finding that Ad5 induces hemagglutination of human erythrocytes as well should be considered interpreting toxicological data in future studies.
The ability of Ad5 to adhere to the surface of human red cells might also explain some findings of past clinical trials. It remained unexplained why large amounts of virus particles were found in the bone marrow of one patient participating in a clinical trial for the correction of a monogenetic disease of the liver. 18 It is possible that Ad5 has not only an increased affinity to mature red cells in humans but also to premature bone marrow standing cells of the red-line-like erythroblasts.
In summary, the affinity between adenoviral vectors and erythrocytes is a species specific property that varies substantially between common animal models and humans. Apart from the relevance of this phenomenon for titration protocols, an increased affinity between adenovirus particles to erythrocytes holds the potency to influence physical and biological aspects of gene transfer in mammalians in a complex manner. This property of Ad5 deserves attention in future preclinical and clinical trials.
